These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 28640877)
1. Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes. Marthaler AM; Podgorska M; Feld P; Fingerle A; Knerr-Rupp K; Grässer F; Smola H; Roemer K; Ebert E; Kim YJ; Bohle RM; Müller CSL; Reichrath J; Vogt T; Malejczyk M; Majewski S; Smola S PLoS Pathog; 2017 Jun; 13(6):e1006406. PubMed ID: 28640877 [TBL] [Abstract][Full Text] [Related]
2. The cutaneous beta human papillomavirus type 8 E6 protein induces CCL2 through the CEBPα/miR-203/p63 pathway to support an inflammatory microenvironment in epidermodysplasia verruciformis skin lesions. Vella L; Sternjakob A; Lohse S; Fingerle A; Sperling T; Wickenhauser C; Stöckle M; Vogt T; Roemer K; Ołdak M; Smola S Front Cell Infect Microbiol; 2024; 14():1336492. PubMed ID: 38510961 [TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration. Sperling T; Ołdak M; Walch-Rückheim B; Wickenhauser C; Doorbar J; Pfister H; Malejczyk M; Majewski S; Keates AC; Smola S PLoS Pathog; 2012; 8(7):e1002833. PubMed ID: 22911498 [TBL] [Abstract][Full Text] [Related]
4. Chronic Inflammatory Microenvironment in Epidermodysplasia Verruciformis Skin Lesions: Role of the Synergism Between HPV8 E2 and C/EBPβ to Induce Pro-Inflammatory S100A8/A9 Proteins. Podgórska M; Ołdak M; Marthaler A; Fingerle A; Walch-Rückheim B; Lohse S; Müller CSL; Vogt T; Ustav M; Wnorowski A; Malejczyk M; Majewski S; Smola S Front Microbiol; 2018; 9():392. PubMed ID: 29563902 [TBL] [Abstract][Full Text] [Related]
5. Transcription Properties of Beta-HPV8 and HPV38 Genomes in Human Keratinocytes. Rehm TM; Straub E; Forchhammer S; Leiter U; Iftner T; Stubenrauch F J Virol; 2022 Dec; 96(23):e0149822. PubMed ID: 36394329 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation. Meyers JM; Uberoi A; Grace M; Lambert PF; Munger K PLoS Pathog; 2017 Jan; 13(1):e1006171. PubMed ID: 28107544 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus mediated inhibition of DNA damage sensing and repair drives skin carcinogenesis. Hufbauer M; Cooke J; van der Horst GT; Pfister H; Storey A; Akgül B Mol Cancer; 2015 Oct; 14():183. PubMed ID: 26511842 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2. Fujii T; Shimada K; Asano A; Tatsumi Y; Yamaguchi N; Yamazaki M; Konishi N Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548144 [TBL] [Abstract][Full Text] [Related]
9. The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms. Müller-Schiffmann A; Beckmann J; Steger G J Virol; 2006 Sep; 80(17):8718-28. PubMed ID: 16912319 [TBL] [Abstract][Full Text] [Related]
10. The Protein Tyrosine Phosphatase H1 PTPH1 Supports Proliferation of Keratinocytes and is a Target of the Human Papillomavirus Type 8 E6 Oncogene. Taute S; Böhnke P; Sprissler J; Buchholz S; Hufbauer M; Akgül B; Steger G Cells; 2019 Mar; 8(3):. PubMed ID: 30875834 [TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor 5.2 acts as a transcription repressor of Epidermodysplasia verruciformis-associated human papillomaviruses. Akgül B; Cürten M; Haigis H; Rogosz I; Pfister H Arch Virol; 2006 Dec; 151(12):2461-73. PubMed ID: 16773233 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 8 E6 oncoprotein inhibits transcription of the PDZ protein syntenin-2. Lazić D; Hufbauer M; Zigrino P; Buchholz S; Kazem S; Feltkamp MC; Mauch C; Steger G; Pfister H; Akgül B J Virol; 2012 Aug; 86(15):7943-52. PubMed ID: 22623796 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus 8 E6 disrupts terminal skin differentiation and prevents pro-Caspase-14 cleavage. Kazem S; van der Meijden E; Struijk L; de Gruijl FR; Feltkamp MC Virus Res; 2012 Feb; 163(2):609-16. PubMed ID: 22230316 [TBL] [Abstract][Full Text] [Related]
15. Transduction of the E6 and E7 genes of epidermodysplasia-verruciformis-associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures. Boxman IL; Mulder LH; Noya F; de Waard V; Gibbs S; Broker TR; ten Kate F; Chow LT; ter Schegget J J Invest Dermatol; 2001 Dec; 117(6):1397-404. PubMed ID: 11886500 [TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Deau MC; Favre M; Orth G Virology; 1991 Oct; 184(2):492-503. PubMed ID: 1653484 [TBL] [Abstract][Full Text] [Related]
17. The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. Azzimonti B; Dell'oste V; Borgogna C; Mondini M; Gugliesi F; De Andrea M; Chiorino G; Scatolini M; Ghimenti C; Landolfo S; Gariglio M Virology; 2009 Jun; 388(2):260-9. PubMed ID: 19398117 [TBL] [Abstract][Full Text] [Related]
18. The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes. Oldak M; Smola H; Aumailley M; Rivero F; Pfister H; Smola-Hess S J Virol; 2004 Oct; 78(19):10738-46. PubMed ID: 15367640 [TBL] [Abstract][Full Text] [Related]
19. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control. Connolly K; Manders P; Earls P; Epstein RJ Cancer Treat Rev; 2014 Mar; 40(2):205-14. PubMed ID: 24051018 [TBL] [Abstract][Full Text] [Related]
20. HPV8-induced STAT3 activation led keratinocyte stem cell expansion in human actinic keratoses. Morgan HJ; Olivero C; Shorning BY; Gibbs A; Phillips AL; Ananthan L; Lim AXH; Martuscelli L; Borgogna C; De Andrea M; Hufbauer M; Goodwin R; Akgül B; Gariglio M; Patel GK JCI Insight; 2024 Jun; 9(15):. PubMed ID: 38916963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]